98 related articles for article (PubMed ID: 26932725)
1. Follow-up of Patients Treated for pT1aN0M0 Breast Cancer: 10-year Survival and Prognostic Factors.
Crochet P; Molinari N; Darmon JC; Cutuli B; Serin D
Breast J; 2016 May; 22(3):363-5. PubMed ID: 26932725
[No Abstract] [Full Text] [Related]
2. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
3. Outcome of small invasive breast cancer with no axillary lymph node involvement.
Sánchez-Muñoz A; Pérez-Ruiz E; Jurado JM; Ribelles N; Márquez A; Miramón J; Maíz M; Pajares B; Gallego E; Scholtz V; Jiménez B; Soler C; Molina M; García-Ríos I; Alba E
Breast J; 2011; 17(1):32-8. PubMed ID: 21129091
[TBL] [Abstract][Full Text] [Related]
4. Early-stage young breast cancer patients: impact of local treatment on survival.
Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
[TBL] [Abstract][Full Text] [Related]
5. [Ultraconservative treatment in stage I and II breast carcinoma. Results of a long-term follow-up on 500 operated breasts].
Mencacci R; Alessandroni L; Arcangeli G; Bertolini R; Cecera A; Lopez M; Mardarella C; Parisi A; Tersigni R
Minerva Chir; 2010 Aug; 65(4):401-7. PubMed ID: 20802429
[TBL] [Abstract][Full Text] [Related]
6. Time interval from breast-conserving surgery to breast irradiation in early stage node-negative breast cancer: 17-year follow-up results and patterns of recurrence.
Vujovic O; Yu E; Cherian A; Dar AR; Stitt L; Perera F
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):319-24. PubMed ID: 25636757
[TBL] [Abstract][Full Text] [Related]
7. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
Hong R; Dai Z; Zhu W; Xu B
PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
[TBL] [Abstract][Full Text] [Related]
8. Small tumor size and node-negative HER2-positive breast cancer: a step forward for a better treatment?
Crivellari D; Molino A
J Clin Oncol; 2010 Jun; 28(16):e257; author reply e258-9. PubMed ID: 20368536
[No Abstract] [Full Text] [Related]
9. Long-term cardiovascular mortality after radiotherapy for breast cancer.
Bouillon K; Haddy N; Delaloge S; Garbay JR; Garsi JP; Brindel P; Mousannif A; Lê MG; Labbe M; Arriagada R; Jougla E; Chavaudra J; Diallo I; Rubino C; de Vathaire F
J Am Coll Cardiol; 2011 Jan; 57(4):445-52. PubMed ID: 21251585
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
11. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
12. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
[TBL] [Abstract][Full Text] [Related]
13. [Multi-modal treatment in breast cancer. The prognostic role and correlation between relapse and metastasis].
Munteanu A; Munteanu F; Bild E
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):941-6. PubMed ID: 20191859
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.
Kim YJ; Kim K
Breast; 2017 Apr; 32():26-32. PubMed ID: 28013032
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy.
Meyer A; Dörk T; Sohn C; Karstens JH; Bremer M
Radiother Oncol; 2007 Mar; 82(3):349-53. PubMed ID: 17250914
[TBL] [Abstract][Full Text] [Related]
16. [Is breast saving therapy of breast carcinoma without postoperative radiotherapy justified?].
Schön M; Liebeskind U; Peek U; Schlag PM
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():105-7. PubMed ID: 9101779
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
[TBL] [Abstract][Full Text] [Related]
18. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
[TBL] [Abstract][Full Text] [Related]
19. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
20. Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-year results of trial and out-trial patients.
Martelli G; Boracchi P; Orenti A; Lozza L; Maugeri I; Vetrella G; Agresti R
Eur J Surg Oncol; 2014 Jul; 40(7):805-12. PubMed ID: 24768443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
